SUNOSI® (Solriamfetol) Pregnancy Registry

RecruitingOBSERVATIONAL
Enrollment

1,731

Participants

Timeline

Start Date

July 31, 2019

Primary Completion Date

September 30, 2029

Study Completion Date

September 30, 2029

Conditions
NarcolepsyObstructive Sleep ApneaPregnant Women and Their Offspring
Interventions
DRUG

Sunosi (solriamfetol)

Exposure to at least 1 dose of solriamfetol at any time during pregnancy.

DRUG

Other prescription wake-promoting medications or stimulants

Exposure to at least 1 dose of a prescription wake-promoting medication or stimulant at any time during pregnancy.

OTHER

No treatment

No treatment

Trial Locations (2)

27560

RECRUITING

Evidera, a PPD business unit, Morrisville

28401

RECRUITING

PPD, Inc., Wilmington

Sponsors
All Listed Sponsors
lead

Axsome Therapeutics, Inc.

INDUSTRY

NCT06413420 - SUNOSI® (Solriamfetol) Pregnancy Registry | Biotech Hunter | Biotech Hunter